Understanding new EU pharmacovigilance rules

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1344, 2011-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strengthening and Rationalizing Pharmacovigilance in the EU: Where is Europe Heading to?: A Review of the New EU Legislation on Pharmacovigilance

By Borg John-Joseph  

Drug Safety, Vol. 34, Iss. 3, 2011-03 ,pp. : 187-197

Adis International

Access to resources Recommend Favorite

New rules on pharmacovigilance in Europe: more of the same?

By Brown E.  

International Journal of Pharmaceutical Medicine, Vol. 16, Iss. 1, 2002-02 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

The New EU Legislation on Pharmacovigilance and Changing Models for Drug Development

By Callréus Torbjörn  

Drug Safety, Vol. 34, Iss. 6, 2011-06 ,pp. : 529-530

Adis International

Access to resources Recommend Favorite

Council of the EU moves to strengthen pharmacovigilance

By  

Reactions Weekly, Vol. 1, Iss. 1331, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Communicating the New Pharmacovigilance Landscape

By Edwards I. Ralph  

Drug Safety, Vol. 35, Iss. 12, 2012-12 ,pp. : 1085-1089

Adis International

Access to resources Recommend Favorite